J9277Drugs Administered Other than Oral Method
Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
Short description: Pembrolizumab 1mg berahyalur
- Effective date
- April 1, 2026
- Termination date
- —
Related codes (J-series)
J0013Esketamine, nasal sprayJ0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injectionJ0121Inj., omadacycline, 1 mgJ0122Inj., eravacycline, 1 mgJ0129Abatacept injectionJ0130Abciximab injectionJ0131Inj, acetaminophen (nos)J0132Acetylcysteine injectionJ0133Acyclovir injectionJ0134Inj acetaminophen -freseniusJ0135Adalimumab injection
Frequently asked questions
What is HCPCS code J9277?
J9277 is a HCPCS Level II code for Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph.
What category is HCPCS code J9277 in?
J9277 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.
When did HCPCS code J9277 become effective?
J9277 has been effective since April 1, 2026, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.